We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Allianz Asset Management
101
Allianz Asset Management
Germany
$309K -$195K -36,000 -37%
Simplex Trading
102
Simplex Trading
Illinois
$305K +$92.6K +17,076 +38%
Teacher Retirement System of Texas
103
Teacher Retirement System of Texas
Texas
$298K -$27K -4,976 -8%
QPW
104
Quantum Private Wealth
Florida
$295K -$6.73K -1,241 -2%
VEA
105
Virtus ETF Advisers
New York
$290K +$142K +26,180 +81%
ASRS
106
Arizona State Retirement System
Arizona
$278K +$11.5K +2,115 +4%
Natixis Advisors
107
Natixis Advisors
Massachusetts
$269K -$2.32K -428 -0.8%
Principal Financial Group
108
Principal Financial Group
Iowa
$267K +$8.76K +1,616 +3%
Russell Investments Group
109
Russell Investments Group
United Kingdom
$259K +$202K +37,300 +250%
Cambridge Investment Research Advisors
110
Cambridge Investment Research Advisors
Iowa
$252K -$14.6K -2,698 -5%
RJFSA
111
Raymond James Financial Services Advisors
Florida
$249K +$159K +29,261 +140%
PVI
112
Pura Vida Investments
New York
$248K +$271K +50,000 New
EAM
113
Erste Asset Management
Austria
$243K
TRCT
114
Tower Research Capital (TRC)
New York
$238K -$300K -55,398 -54%
JCM
115
Jacobi Capital Management
Pennsylvania
$228K -$8.13K -1,500 -3%
ProShare Advisors
116
ProShare Advisors
Maryland
$228K +$19.8K +3,650 +9%
RJA
117
Raymond James & Associates
Florida
$197K -$927K -170,987 -81%
DT
118
Diversified Trust
Tennessee
$194K
WG
119
Winton Group
United Kingdom
$188K +$38.2K +7,045 +23%
NC
120
NinePointTwo Capital
California
$186K +$204K +37,533 New
SG Americas Securities
121
SG Americas Securities
New York
$185K -$23.7K -4,371 -10%
MNBTD
122
Moody National Bank Trust Division
Texas
$179K +$121K +22,396 +165%
CIC
123
Cornercap Investment Counsel
Georgia
$179K +$1.27K +234 +0.7%
Public Employees Retirement Association of Colorado
124
Public Employees Retirement Association of Colorado
Colorado
$173K
Zurich Cantonal Bank
125
Zurich Cantonal Bank
Switzerland
$165K -$2.81K -518 -2%

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.